Fenghuangzhiyao Tiandan Tongluo Jiaonang For Cerebrovascular Disease 0.4g*60 Capsules

(No reviews yet) Write a Review
US $21.99
SKU:
BL013
Shipping:
Calculated at Checkout
Origin:
China
Form:
Capsules
Adding to cart… The item has been added

Product Overview

Generic name: Tiandan Tongluo Capsule
Chinese Pinyin: TianDanTuoLuoJiaoNang
Product name: Phoenix Pharmaceutical
Ingredients: Ligusticum chuanxiong, Siegesbeckiae, Salvia miltiorrhiza, Leech, Gastrodia, Sophora japonicus, Acorus calamus, artificial bezoar, astragalus, Achyranthes
Properties: This product is a capsule, the content is yellow-brown powder; the taste is bitter and slightly astringent.
Functions and indications: Promoting blood circulation and dredging collaterals, eliminating wind and phlegm It is used for the syndrome of meridian in stroke, wind phlegm and blood stasis to obstruct the veins and collaterals. Symptoms are hemiplegia, numbness of the body, crooked mouth and eyes, language stubbornness; those who see the above syndromes in the acute stage of cerebral infarction and early recovery.
Specification: 0.4g*60 capsules/box
Usage and dosage: Orally, 5 capsules each time, 3 times a day.
Adverse reactions: not yet clear
Contraindications: Patients with cerebral hemorrhage are disabled in the acute phase.
Note: Don't eat cold, spicy, and greasy food.
Drug interactions: Test pharmacology results show that this product has the effects of inhibiting blood coagulation system, improving blood fiber activity, inhibiting thrombosis, promoting thrombolysis, and anti-cerebral ischemia.

1. Inhibit rat platelet aggregation and promote the de-aggregation of aggregated platelets.

2. It can prolong prothrombin, thrombin and kaolin partial thromboplastin time, and prolong the clotting time of rats.

3. Shorten the dissolution time of rat euglobulin.

4. Improve blood rheology in hormonal blood stasis rats.

5. Extend the time of rat arterial thrombosis caused by current stimulation.

6. Reduce the permeability of cerebral blood vessels and the water content of brain tissue in rats with acute cerebral ischemia caused by surgical ligation.

7. Reduce the degree of cerebral ischemic lesions caused by electric heating block the middle cerebral artery in rats.

Toxicological research: the results of oral acute toxicity test in mice, the maximum dose is 375.15g crude drug/Kg. According to the results of 60-day long-term toxicity test in rats, the maximum non-toxic reaction dose was 56.28 crude drug/Kg.
Pharmacology and Toxicology: Unclear
Storage: sealed.
Packaging: Plastic bottle, 60 capsules per bottle.
Validity period: 24 months
Approval number: National Pharmaceutical Standard Z20010029
Company Name: Shandong Phoenix Pharmaceutical Co., Ltd.

Reviews

(No reviews yet) Write a Review